Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS

NCT01104298 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

115

Enrollment

OTHER

Sponsor class

Stopped Interim analysis did not show good results for main objective

Conditions

Sarcoma

Interventions

DRUG: Doxorubicin
DRUG: Trabectedin

Sponsor

Grupo Espanol de Investigacion en Sarcomas